Bank Of America Corp Aurinia Pharmaceuticals Inc. Transaction History
Bank Of America Corp
- $1.19 Trillion
- Q3 2024
A detailed history of Bank Of America Corp transactions in Aurinia Pharmaceuticals Inc. stock. As of the latest transaction made, Bank Of America Corp holds 174,690 shares of AUPH stock, worth $1.4 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
174,690
Previous 152,374
14.65%
Holding current value
$1.4 Million
Previous $870,000
47.13%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding AUPH
# of Institutions
214Shares Held
58.3MCall Options Held
1.14MPut Options Held
1.51M-
Black Rock Inc. New York, NY9.27MShares$74.3 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY8.2MShares$65.7 Million1.0% of portfolio
-
Tang Capital Management LLC San Diego, CA7.23MShares$57.9 Million4.52% of portfolio
-
Nea Management Company, LLC Timonium, MD3.97MShares$31.8 Million2.22% of portfolio
-
State Street Corp Boston, MA2.95MShares$23.6 Million0.0% of portfolio
About Aurinia Pharmaceuticals Inc.
- Ticker AUPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,892,000
- Market Cap $1.14B
- Description
- Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...